ALLAN FERNANDEZ: Open Payments
NPI 1144597527 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 54 payments from 12 companies in 2025. Trend: 2023 $828 · 2024 $1,246 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $595 |
| Braeburn Inc. | 7 | $216 |
| Exact Sciences Corporation | 4 | $84 |
| Orexo US, Inc. | 3 | $63 |
| Indivior Inc. | 2 | $61 |
| Gilead Sciences, Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: VRAYLAR, BRIXADI, Zubsolv, SUBLOCADE, VOQUEZNA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, MAVYRET.
Industry payments across NY — which companies pay providers there.
